Articles published by Vogenx, Inc.
Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia
October 15, 2026
From Vogenx, Inc.
Via ACCESS Newswire
Tickers
VOGX
From Vogenx, Inc.
Via ACCESS Newswire
Tickers
VOGX
Vogenx Appoints Ken Toombs to Board of Directors
September 22, 2026
From Vogenx, Inc.
Via ACCESS Newswire
Tickers
VOGX
Vogenx Announces Closing of Initial Public Offering
August 13, 2026
From Vogenx, Inc.
Via ACCESS Newswire
Tickers
VOGX
Vogenx Announces Pricing of Initial Public Offering
August 11, 2026
From Vogenx, Inc.
Via ACCESS Newswire